These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6436946)

  • 21. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin-dependent cellular cytotoxicity by human lymphocytes is blocked by monoclonal antibodies to the sheep red cell receptor.
    Görög G; Laskay T; Petrányi GG
    Immunol Lett; 1985; 11(2):107-9. PubMed ID: 3936780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.
    Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
    Ann N Y Acad Sci; 1993 Aug; 690():337-9. PubMed ID: 8368748
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new set of monoclonal antibodies against acute lymphoblastic leukemia.
    Boucheix C; Perrot JY; Mirshahi M; Giannoni F; Billard M; Bernadou A; Rosenfeld C
    Leuk Res; 1985; 9(5):597-604. PubMed ID: 2409408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
    Macintyre EA
    Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
    [No Abstract]   [Full Text] [Related]  

  • 28. Production and characterization of monoclonal antibodies to guinea pig lymphoid differentiation antigens.
    Chiba J; Chused TM; Leiserson WM; Zweig SE; Shevach EM
    J Immunol Methods; 1983 Oct; 63(2):247-61. PubMed ID: 6413591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic modulation of pan-T-cell and T-cell subset-specific markers.
    Estabrook A; Mittler R; LoGerfo P; Hardy M; Edelson RL; Berger CL
    Diagn Immunol; 1983; 1(3):199-204. PubMed ID: 6209055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-bound anti-CD3 monoclonal antibodies trigger cytolytic T-lymphocyte-mediated tumor lysis.
    Mentzer SJ; Wilson RE; Burakoff SJ; Herrmann SH
    Arch Surg; 1988 Oct; 123(10):1280-5. PubMed ID: 3263103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serological analysis of human cancer. Identification of differentiation antigens on melanoma and melanocytes.
    Houghton AN
    Prog Clin Biol Res; 1983; 119():199-205. PubMed ID: 6867027
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of T-cell subsets defined by monoclonal antibodies in human diseases.
    Bach JF; Chatenoud L
    Ann Immunol (Paris); 1982; 133D(2):131-6. PubMed ID: 6187268
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-K562 monoclonal antibodies that recognize antigens on immature hematopoietic cells.
    Young NS; Gallagher RE; Chen SP
    Prog Clin Biol Res; 1983; 134():293-304. PubMed ID: 6686680
    [No Abstract]   [Full Text] [Related]  

  • 36. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
    Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
    J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-L3T4 monoclonal antibody inhibits T-cell activation by anti-T-cell receptor antibody through a pathway not involving "associative recognition".
    Moldwin RL; Nau GJ; Havran WL; Lancki DW; Fitch FW
    Ann Inst Pasteur Immunol; 1987; 138(1):131-4. PubMed ID: 3107585
    [No Abstract]   [Full Text] [Related]  

  • 39. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
    Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
    Vrionis FD; Wikstrand CJ; Bigner DD
    Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.